Table 2.

Association between pain phenotype and presence of comorbidities

	Nociceptive pain phenotype	Non-nociceptive pain phenotype	OR (95% CI)	p
Comorbidity total, mean (SD)	5.92 (3.71)	6.42 (4.10)	1.03 (0.96–1.12)	0.391
Cardiovascular, median (IQR)	0 (0–1)	0 (0–1)	1.08 (0.59–1.98)	0.973
Malignancies, median (IQR)	0 (0–0)	0 (0–0)	0.96 (0.44–2.13)	0.895
Infections, median (IQR)	0 (0–1)	0 (0–1)	0.73 (0.40–1.34)	0.381
Gastrointestinal, median (IQR)	0 (0–1)	0 (0–1)	1.18 (0.61–2.28)	0.614
Pain associated, median (IQR)	2 (0.5–3)	3 (1–4)	1.95 (1.06–3.59)	0.041
Remaining, median (IQR)	1 (0–2)	1 (0–3)	0.64 (0.33–1.22)	0.681
Osteoporosis, n (%)	14 (12.8%)	7 (9.9%)	0.74 (0.28–1.94)	0.544
Depression, n (%)	4 (3.7%)	0 (0%)	N/A
Fibromyalgia, n (%)	1 (0.9%)	7 (9.9%)	11.8 (1.42–98.2)	0.004